Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 168

1.

Vaping cannabis among adolescents: prevalence and associations with tobacco use from a cross-sectional study in the USA.

Kowitt SD, Osman A, Meernik C, Zarkin GA, Ranney LM, Martin J, Heck C, Goldstein AO.

BMJ Open. 2019 Jun 13;9(6):e028535. doi: 10.1136/bmjopen-2018-028535.

2.

Adolescents' first tobacco products: Associations with current multiple tobacco product use.

Kowitt SD, Goldstein AO, Sutfin EL, Osman A, Meernik C, Heck C, Ranney LM.

PLoS One. 2019 May 23;14(5):e0217244. doi: 10.1371/journal.pone.0217244. eCollection 2019.

3.

Changes in Physician Knowledge, Attitudes, Beliefs, and Practices Regarding Lung Cancer Screening.

Henderson LM, Benefield TS, Bearden SC, Reuland DS, Brenner AT, Goldstein AO, Throneburg A, Rivera MP.

Ann Am Thorac Soc. 2019 May 10. doi: 10.1513/AnnalsATS.201812-867RL. [Epub ahead of print] No abstract available.

PMID:
31075047
4.

Opinions and Practices of Lung Cancer Screening by Physician Specialty.

Henderson LM, Marsh MW, Benefield TS, Jones LM, Reuland DS, Brenner AT, Goldstein AO, Molina PL, Maygarden SJ, Rivera MP.

N C Med J. 2019 Jan-Feb;80(1):19-26. doi: 10.18043/ncm.80.1.19.

5.

Adolescents' Aided Recall of Targeted and Non-Targeted Tobacco Communication Campaigns in the United States.

Kowitt SD, Lazard AJ, Queen TL, Noar SM, Goldstein AO.

Int J Environ Res Public Health. 2018 Oct 25;15(11). pii: E2363. doi: 10.3390/ijerph15112363.

6.

Trends and Racial Disparities in Mono, Dual, and Poly Use of Tobacco Products Among Youth.

Osman A, Kowitt SD, Ranney LM, Heck C, Goldstein AO.

Nicotine Tob Res. 2018 Aug 14;20(suppl_1):S22-S30. doi: 10.1093/ntr/nty051.

7.

A Narrative Review of Intensive Group Tobacco Treatment: Clinical, Research, and U.S. Policy Recommendations.

Kotsen C, Santorelli ML, Bloom EL, Goldstein AO, Ripley-Moffitt C, Steinberg MB, Burke MV, Foulds J.

Nicotine Tob Res. 2018 Aug 17. doi: 10.1093/ntr/nty162. [Epub ahead of print]

PMID:
30124924
8.

Billing Practices Among US Tobacco Use Treatment Providers.

Bloom EL, Burke MV, Kotsen C, Goldstein AO, Ripley-Moffitt C, Steinberg MB, Dailey M, Hunt LE, Bars MP.

J Addict Med. 2018 Sep/Oct;12(5):381-386. doi: 10.1097/ADM.0000000000000423.

PMID:
30044243
9.

Examining Patient Perspectives on Weight Management Support in the Primary Care Setting.

Bloom K, Adler J, Bridges C, Bernstein J, Rini C, Goldstein AO, Ripley-Moffitt C.

J Prim Prev. 2018 Aug;39(4):387-399. doi: 10.1007/s10935-018-0516-9.

PMID:
30008041
10.

Treating Tobacco Use in Patients with Incurable Malignancies: Should We Even Start the Conversation?

Trout S, Goldstein AO, Marks L, Ripley-Moffitt C.

J Palliat Med. 2018 Jun;21(6):746-750. doi: 10.1089/jpm.2017.0304. Epub 2018 May 7.

11.

The effect of cigarillo packaging elements on young adult perceptions of product flavor, taste, smell, and appeal.

Meernik C, Ranney LM, Lazard AJ, Kim K, Queen TL, Avishai A, Boynton MH, Sheeran PJ, Goldstein AO.

PLoS One. 2018 Apr 19;13(4):e0196236. doi: 10.1371/journal.pone.0196236. eCollection 2018.

12.

Information to Improve Public Perceptions of the Food and Drug Administration (FDA's) Tobacco Regulatory Role.

Osman A, Kowitt SD, Sheeran P, Jarman KL, Ranney LM, Goldstein AO.

Int J Environ Res Public Health. 2018 Apr 14;15(4). pii: E753. doi: 10.3390/ijerph15040753.

13.

Attitudes Toward FDA Regulation of Newly Deemed Tobacco Products.

Kowitt SD, Goldstein AO, Schmidt AM, Hall MG, Brewer NT.

Tob Regul Sci. 2017 Oct;3(4):504-515. doi: 10.18001/TRS.3.4.10. Epub 2017 Oct 1.

14.

Opinions, practice patterns, and perceived barriers to lung cancer screening among attending and resident primary care physicians.

Henderson LM, Jones LM, Marsh MW, Brenner AT, Goldstein AO, Benefield TS, Greenwood-Hickman MA, Molina PL, Rivera MP, Reuland DS.

Risk Manag Healthc Policy. 2018 Jan 22;10:189-195. doi: 10.2147/RMHP.S143152. eCollection 2017.

15.

Factors Influencing Trust in Agencies That Disseminate Tobacco Prevention Information.

Ranney LM, Jarman KL, Baker HM, Vu M, Noar SM, Goldstein AO.

J Prim Prev. 2018 Apr;39(2):99-116. doi: 10.1007/s10935-018-0501-3.

16.

E-Cigarette Use Among Adolescents Not Susceptible to Using Cigarettes.

Kowitt SD, Osman A, Ranney LM, Heck C, Goldstein AO.

Prev Chronic Dis. 2018 Feb 1;15:E18. doi: 10.5888/pcd15.170368.

17.

Continuing Medical Education and Firearm Violence Counseling.

Damari ND, Ahluwalia KS, Viera AJ, Goldstein AO.

AMA J Ethics. 2018 Jan 1;20(1):56-68. doi: 10.1001/journalofethics.2018.20.1.stas1-1801.

18.

Attitudes towards Potential New Tobacco Control Regulations among U.S. Adults.

Schmidt AM, Kowitt SD, Myers AE, Goldstein AO.

Int J Environ Res Public Health. 2018 Jan 5;15(1). pii: E72. doi: 10.3390/ijerph15010072.

19.

Perceptions of Tobacco Control Media Campaigns Among Smokers With Lower Socioeconomic Status.

McCullough A, Meernik C, Baker H, Jarman K, Walsh B, Goldstein AO.

Health Promot Pract. 2018 Jul;19(4):550-559. doi: 10.1177/1524839917741485. Epub 2017 Nov 30.

PMID:
29190143
20.

Using Lean Quality Improvement Tools to Increase Delivery of Evidence-Based Tobacco Use Treatment in Hospitalized Neurosurgical Patients.

Sisler L, Omofoye O, Paci K, Hadar E, Goldstein AO, Ripley-Moffitt C.

Jt Comm J Qual Patient Saf. 2017 Dec;43(12):633-641. doi: 10.1016/j.jcjq.2017.06.012.

PMID:
29173283
21.

Should the Legal Age for Tobacco Be Raised? Results From a National Sample of Adolescents.

Kowitt SD, Schmidt AM, Myers AE, Goldstein AO.

Prev Chronic Dis. 2017 Nov 16;14:E112. doi: 10.5888/pcd14.170255.

22.

Use of Expired Air Carbon Monoxide Testing in Clinical Tobacco TreatmentĀ Settings.

Goldstein AO, Gans SP, Ripley-Moffitt C, Kotsen C, Bars M.

Chest. 2018 Feb;153(2):554-562. doi: 10.1016/j.chest.2017.11.002. Epub 2017 Nov 11. Review.

PMID:
29137909
23.

Are Some of the Cigar Warnings Mandated in the U.S. More Believable Than Others?

Jarman KL, Kowitt SD, Cornacchione Ross J, Goldstein AO.

Int J Environ Res Public Health. 2017 Nov 10;14(11). pii: E1370. doi: 10.3390/ijerph14111370.

24.

Provider satisfaction with an inpatient tobacco treatment program: results from an inpatient provider survey.

Trout S, Ripley-Moffitt C, Meernik C, Greyber J, Goldstein AO.

Int J Gen Med. 2017 Oct 19;10:363-369. doi: 10.2147/IJGM.S136965. eCollection 2017.

25.

Public Knowledge and Credibility Perceptions of the FDA as a Tobacco Regulator.

Schmidt AM, Jarman KL, Ranney LM, Queen TL, Noar SM, Ruel L, Agans R, Hannan A, Goldstein AO.

Nicotine Tob Res. 2018 Sep 25;20(11):1310-1316. doi: 10.1093/ntr/ntx215.

PMID:
29059369
26.

Cigarette Constituent Health Communications for Smokers: Impact of Chemical, Imagery, and Source.

Kowitt SD, Sheeran P, Jarman KL, Ranney LM, Schmidt AM, Noar SM, Huang LL, Goldstein AO.

Nicotine Tob Res. 2019 May 21;21(6):841-845. doi: 10.1093/ntr/ntx226.

27.

Believability of Cigarette Warnings About Addiction: National Experiments of Adolescents and Adults.

Lazard AJ, Kowitt SD, Huang LL, Noar SM, Jarman KL, Goldstein AO.

Nicotine Tob Res. 2018 Jun 7;20(7):867-875. doi: 10.1093/ntr/ntx185.

28.

Perceptions of the Food and Drug Administration as a Tobacco Regulator.

Jarman KL, Ranney LM, Baker HM, Vallejos QM, Goldstein AO.

Tob Regul Sci. 2017 Apr;3(2):239-247. doi: 10.18001/TRS.3.2.12. Epub 2017 Apr 1.

29.

Erratum to: understanding how perceptions of tobacco constituents and the FDA relate to effective and credible tobacco risk messaging: a national phone survey of U.S. adults, 2014-2015.

Boynton MH, Agans RP, Michael Bowling J, Brewer NT, Sutfin EL, Goldstein AO, Noar SM, Ribisl KM.

BMC Public Health. 2017 Sep 20;17(1):726. doi: 10.1186/s12889-017-4760-3. No abstract available.

30.

Evaluation of Community-Based Cessation Programs: How Do Smokers with Behavioral Health Conditions Fare?

Meernik C, McCullough A, Ranney L, Walsh B, Goldstein AO.

Community Ment Health J. 2018 Feb;54(2):158-165. doi: 10.1007/s10597-017-0155-2. Epub 2017 Aug 2.

PMID:
28770359
31.

Development of the FDA Tobacco Credibility Scale (FDA-TCS).

Schmidt AM, Ranney LM, Noar SM, Goldstein AO.

Tob Regul Sci. 2017 Jan;3(1):47-55. doi: 10.18001/TRS.3.1.5.

32.

Consumers' Preferences for Electronic Nicotine Delivery System Product Features: A Structured Content Analysis.

Kistler CE, Crutchfield TM, Sutfin EL, Ranney LM, Berman ML, Zarkin GA, Goldstein AO.

Int J Environ Res Public Health. 2017 Jun 7;14(6). pii: E613. doi: 10.3390/ijerph14060613.

33.

Trends and Correlates of Hookah Use Among High School Students in North Carolina.

Huang LL, Sutfin EL, Kowitt S, Patel T, Ranney L, Goldstein AO.

N C Med J. 2017 May-Jun;78(3):149-155. doi: 10.18043/ncm.78.3.149.

34.

Awareness and trust of the FDA and CDC: Results from a national sample of US adults and adolescents.

Kowitt SD, Schmidt AM, Hannan A, Goldstein AO.

PLoS One. 2017 May 16;12(5):e0177546. doi: 10.1371/journal.pone.0177546. eCollection 2017.

35.

Providing Nicotine Replacement Therapy in Focus Groups.

Jones EE, Jarman KL, Goldstein AO.

Nicotine Tob Res. 2018 Feb 7;20(3):399-400. doi: 10.1093/ntr/ntx090. No abstract available.

36.

Perceptions and Experiences with Flavored Non-Menthol Tobacco Products: A Systematic Review of Qualitative Studies.

Kowitt SD, Meernik C, Baker HM, Osman A, Huang LL, Goldstein AO.

Int J Environ Res Public Health. 2017 Mar 23;14(4). pii: E338. doi: 10.3390/ijerph14040338. Review.

37.

Public attitudes toward larger cigarette pack warnings: Results from a nationally representative U.S. sample.

Kowitt SD, Noar SM, Ranney LM, Goldstein AO.

PLoS One. 2017 Mar 2;12(3):e0171496. doi: 10.1371/journal.pone.0171496. eCollection 2017.

38.

Believability of new diseases reported in the 2014 Surgeon General's Report on smoking: Experimental results from a national survey of US adults.

Francis DB, Noar SM, Kowitt SD, Jarman KL, Goldstein AO.

Prev Med. 2017 Jun;99:94-98. doi: 10.1016/j.ypmed.2017.01.021. Epub 2017 Feb 9.

39.

Impact of The Real Cost Campaign on Adolescents' Recall, Attitudes, and Risk Perceptions about Tobacco Use: A National Study.

Huang LL, Lazard AJ, Pepper JK, Noar SM, Ranney LM, Goldstein AO.

Int J Environ Res Public Health. 2017 Jan 4;14(1). pii: E42. doi: 10.3390/ijerph14010042.

40.

Effects of Framing Proximal Benefits of Quitting and Motivation to Quit as a Query on Communications About Tobacco Constituents.

Kowitt S, Sheeran P, Jarman K, Ranney LM, Schmidt AM, Huang LL, Goldstein AO.

Nicotine Tob Res. 2017 Oct 1;19(10):1178-1184. doi: 10.1093/ntr/ntw317.

41.

Believability of Cigar Warning Labels Among Adolescents.

Kowitt SD, Jarman K, Ranney LM, Goldstein AO.

J Adolesc Health. 2017 Mar;60(3):299-305. doi: 10.1016/j.jadohealth.2016.10.007. Epub 2016 Dec 10.

42.

The Tobacco 21 Movement and Electronic Nicotine Delivery System Use Among Youth.

Meernik C, Baker HM, Lee JG, Goldstein AO.

Pediatrics. 2017 Jan;139(1). pii: e20162216. doi: 10.1542/peds.2016-2216. Epub 2016 Dec 6. No abstract available.

43.

Impact of non-menthol flavours in tobacco products on perceptions and use among youth, young adults and adults: a systematic review.

Huang LL, Baker HM, Meernik C, Ranney LM, Richardson A, Goldstein AO.

Tob Control. 2017 Nov;26(6):709-719. doi: 10.1136/tobaccocontrol-2016-053196. Epub 2016 Nov 21. Review.

44.

"The Job Has Become Advocating for the Job": Threats to Funding Dramatically Influence Program Outcomes.

McCullough A, Ranney LM, Simons DJ, Goldstein AO.

Am J Health Promot. 2018 May;32(4):861-864. doi: 10.1177/0890117116674534. Epub 2016 Nov 3.

PMID:
27810950
45.

Eye Tracking Outcomes in Tobacco Control Regulation and Communication: A Systematic Review.

Meernik C, Jarman K, Wright ST, Klein EG, Goldstein AO, Ranney L.

Tob Regul Sci. 2016 Oct;2(4):377-403.

46.

Burns from e-cigarettes and other electronic nicotine delivery systems.

Meernik C, Williams FN, Cairns BA, Grant EJ, Goldstein AO.

BMJ. 2016 Sep 23;354:i5024. doi: 10.1136/bmj.i5024. No abstract available.

PMID:
27664185
47.

Source Credibility in Tobacco Control Messaging.

Schmidt AM, Ranney LM, Pepper JK, Goldstein AO.

Tob Regul Sci. 2016 Jan;2(1):31-37.

48.

Electronic Cigarette Use Among High School Students and Its Association With Cigarette Use And Smoking Cessation, North Carolina Youth Tobacco Surveys, 2011 and 2013.

Huang LL, Kowitt SD, Sutfin EL, Patel T, Ranney LM, Goldstein AO.

Prev Chronic Dis. 2016 Aug 4;13:E103. doi: 10.5888/pcd13.150564.

49.

Should Clinicians Recommend E-cigarettes to Their Patients Who Smoke? No.

Meernik C, Goldstein AO.

Ann Fam Med. 2016 Jul;14(4):302-3. doi: 10.1370/afm.1961. No abstract available.

50.

Understanding how perceptions of tobacco constituents and the FDA relate to effective and credible tobacco risk messaging: A national phone survey of U.S. adults, 2014-2015.

Boynton MH, Agans RP, Bowling JM, Brewer NT, Sutfin EL, Goldstein AO, Noar SM, Ribisl KM.

BMC Public Health. 2016 Jun 23;16:516. doi: 10.1186/s12889-016-3151-5. Erratum in: BMC Public Health. 2017 Sep 20;17 (1):726.

Supplemental Content

Loading ...
Support Center